These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6451857)

  • 1. Drug therapy of aspergillus otitis externa.
    Lopez L; Evens RP
    Otolaryngol Head Neck Surg (1979); 1980; 88(6):649-51. PubMed ID: 6451857
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant otitis externa due to Aspergillus niger.
    Bellini C; Antonini P; Ermanni S; Dolina M; Passega E; Bernasconi E
    Scand J Infect Dis; 2003; 35(4):284-8. PubMed ID: 12839164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.
    Moosa MY; Alangaden GJ; Manavathu E; Chandrasekar PH
    J Antimicrob Chemother; 2002 Jan; 49(1):209-13. PubMed ID: 11751792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal drugs.
    Cartwright RY
    J Antimicrob Chemother; 1975 Jun; 1(2):141-62. PubMed ID: 1100588
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of systemic mycoses.
    Abernathy RS
    Medicine (Baltimore); 1973 Sep; 52(5):385-94. PubMed ID: 4725961
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole.
    Chappe M; Vrignaud S; de Gentile L; Legrand G; Lagarce F; Le Govic Y
    J Mycol Med; 2018 Jun; 28(2):396-398. PubMed ID: 29673769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otomycosis: an entity.
    McGonigle JJ; Jillson OF
    Arch Dermatol; 1967 Jan; 95(1):45-6. PubMed ID: 4224861
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aspergillosis].
    Leshchenko VM
    Vestn Dermatol Venerol; 1968 Jul; 42(7):45-51. PubMed ID: 5307933
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of aspergillus lung disease].
    Scholer HJ
    Mykosen; 1983 Apr; 26(4):173-96. PubMed ID: 6306462
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical invasive external otitis from Aspergillus.
    Bickley LS; Betts RF; Parkins CW
    Arch Otolaryngol Head Neck Surg; 1988 Sep; 114(9):1024-8. PubMed ID: 3408569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An agranulocytic case with Aspergillus diffuse external otitis cured by amphotericin B topic administration].
    Lin YW
    Kansenshogaku Zasshi; 1998 Aug; 72(8):855-6. PubMed ID: 9780592
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.
    Denning DW; Stevens DA
    Rev Infect Dis; 1990; 12(6):1147-201. PubMed ID: 2267490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa.
    Nakano Y; Wada M; Tani H; Sasai K; Baba E
    J Vet Med Sci; 2005 Dec; 67(12):1243-7. PubMed ID: 16397383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic pneumonia caused by Aspergillus niger: is oral cleansing with amphotericin B efficacious in preventing relapse of allergic pneumonitis?
    Ogawa H; Fujimura M; Tofuku Y; Kitagawa M
    J Asthma; 2009 Feb; 46(1):95-8. PubMed ID: 19191146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature.
    Kirby A; Hassan I; Burnie J
    J Infect; 2006 Jun; 52(6):405-14. PubMed ID: 16239033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otomycosis in Burma, and its treatment.
    Than KM; Naing KS; Min M
    Am J Trop Med Hyg; 1980 Jul; 29(4):620-3. PubMed ID: 6447461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental aspergillosis in mice].
    Haller I
    Dermatologica; 1979; 159(Suppl 1):187-90. PubMed ID: 385383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Otic administration of amphotericin B 0.25% in sterile water.
    Kintzel PE; Trausch DE; Copfer AL
    Ann Pharmacother; 1994 Mar; 28(3):333-5. PubMed ID: 8193421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.
    Offner F; Krcmery V; Boogaerts M; Doyen C; Engelhard D; Ribaud P; Cordonnier C; de Pauw B; Durrant S; Marie JP; Moreau P; Guiot H; Samonis G; Sylvester R; Herbrecht R;
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4808-12. PubMed ID: 15561860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
    Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.